4.7 Article

Visual Prognostic Factors in Eyes with Subretinal Fluid Associated with Branch Retinal Vein Occlusion

期刊

JOURNAL OF CLINICAL MEDICINE
卷 12, 期 8, 页码 -

出版社

MDPI
DOI: 10.3390/jcm12082909

关键词

branch retinal vein occlusion; ellipsoid zone; macular edema; optical coherence tomography; subretinal fluid; visual prognostic factor

向作者/读者索取更多资源

We investigated the impact of foveal ellipsoid zone (EZ) status on visual prognosis in eyes with subretinal fluid (SRF) associated with branch retinal vein occlusion (BRVO). We found that baseline intact EZ significantly improved visual prognosis, as its status correlated with the 12-month best-corrected visual acuity (BCVA). The visual acuity of eyes with intact EZ was significantly better than those with disrupted EZ, indicating that foveal EZ status on vertical OCT images can be a novel biomarker for visual prognosis in BRVO-related SRF eyes.
We investigated whether foveal ellipsoid zone (EZ) status affects visual prognosis in eyes with subretinal fluid (SRF) associated with branch retinal vein occlusion (BRVO). We included 38 eyes retrospectively and classified those with or without a continuous EZ on the SRF of the central foveola on the vertical optical coherence tomography (OCT) image at the initial visit as intact (n = 26) and disruptive EZ (n = 12) groups, respectively. In addition, we classified the intact EZ eyes into clear (n = 15) and blurred (n = 11) EZ groups according to whether EZ on the SRF was observed distinctly or not. Multiple regression analyses showed that baseline EZ status significantly correlated (p = 0.0028) with the 12-months logarithm of the minimum angle of resolution (logMAR) best-corrected visual acuity (BCVA), indicating that baseline intact EZ significantly improves visual prognosis. The 12-months logMAR BCVA of the intact EZ group was significantly better (p < 0.001) than that of the disruptive EZ group, and did not differ significantly between the clear and blurred EZ groups. Thus, baseline foveal EZ status on vertical OCT images can be a novel biomarker for visual prognosis in eyes with SRF associated with BRVO.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据